Current approaches for treatment of colonic disorder

Colon diseases, which can range from acute infections to cancer, impose a significant health burden on both men and women worldwide. Many colonic diseases are influenced by environmental and genetic factors, which can affect their onset and prognosis. Recent research has highlighted the importance of inflammation in the development, progression, and outcome of many colonic diseases. In this chapter, we provide an update on this research to help readers understand how genetics, diet, and the gut microbiota impact the communication between immune and nonimmune cells, which in turn affects inflammation in a variety of colonic diseases. Inflammatory bowel disease is a widespread illness that has generated considerable interest among researchers, resulting in a greater understanding of the disease and improved care. We also analyze current and potential medications and treatments that have shown promise in preclinical research and are likely to be useful in the future. Despite advances in treatment, the high mortality rate of colorectal cancer (CRC) is expected to persist in the coming decades. Early-stage CRC is treated with surgery and adjuvant therapy (chemotherapy/radiotherapy), but recurrence is common, and the likelihood of treatment failure increases with cancer medication resistance. Several risk factors contribute to the high incidence of CRC in both sexes.